BFAM Partners

BFAM Partners is a Hong Kong-based hedge fund and alternative investment management firm founded in 2012 by Benjamin Fuchs. The firm focuses on Asian markets, particularly China, and is known for multi-strategy investing with emphasis on distressed, special situations, credit, and absolute-return strategies. BFAM Partners is a financial services company rather than a life sciences, biotech, pharma, or healthcare operating company. Publicly available information indicates it manages private investment funds and uses technology and quantitative infrastructure to support investment operations. Because it is not a drug developer or healthcare services company, it does not have a therapeutic pipeline, clinical stage, or product portfolio in the biotech sense.